Lyra Therapeutics, Inc. (LYRA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.23 |
| Open | 5.25 |
| Bid | 5.13 x 200 |
| Ask | 5.23 x 100 |
| Day's range | 5.13 - 5.27 |
| 52-week range | 2.26 - 6.79 |
| Volume | |
| Avg. volume | 346,324 |
| Market cap | 308.872M |
| Beta (5Y monthly) | 0.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.26 |
| Earnings date | 10 May 2024 - 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.00 |
ZacksLyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
Lyra Therapeutics (LYRA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Simply Wall St.Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well
Key Insights Significant control over Lyra Therapeutics by private equity firms implies that the general public has...
ZacksLyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why
Lyra Therapeutics (LYRA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
© 2024 Yahoo. All rights reserved.